BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 21087745)

  • 21. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve.
    Mussardo M; Latib A; Chieffo A; Godino C; Ielasi A; Cioni M; Takagi K; Davidavicius G; Montorfano M; Maisano F; Carlino M; Franco A; Covello RD; Spagnolo P; Grimaldi A; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2011 Jul; 4(7):743-50. PubMed ID: 21777881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.
    Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A; Eltchaninoff H
    JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical sutureless and transcatheter aortic valves: hemodynamic performance and clinical outcomes in propensity score-matched high-risk populations with severe aortic stenosis.
    Kamperidis V; van Rosendael PJ; de Weger A; Katsanos S; Regeer M; van der Kley F; Mertens B; Sianos G; Ajmone Marsan N; Bax JJ; Delgado V
    JACC Cardiovasc Interv; 2015 Apr; 8(5):670-7. PubMed ID: 25946438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of balloon-expandable valves versus self-expandable valves in high-risk patients undergoing transcatheter aortic valve replacement for severe aortic stenosis.
    Chang HH; Chen IM; Chen PL; Hsu TL; Lin SM; Chen YH
    J Chin Med Assoc; 2015 Jun; 78(6):331-8. PubMed ID: 25823678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The groin first approach for transcatheter aortic valve implantation: are we pushing the limits for transapical implantation?
    Beller CJ; Schmack B; Seppelt P; Arif R; Bekeredjian R; Krumsdorf U; Katus HA; Karck M; Kallenbach K
    Clin Res Cardiol; 2013 Feb; 102(2):111-7. PubMed ID: 22864650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is EuroSCORE II better than EuroSCORE in predicting mortality after transcatheter aortic valve implantation?
    Watanabe Y; Hayashida K; Lefèvre T; Chevalier B; Hovasse T; Romano M; Garot P; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Morice MC
    Catheter Cardiovasc Interv; 2013 May; 81(6):1053-60. PubMed ID: 23074135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anatomic suitability for present and next generation transcatheter aortic valve prostheses: evidence for a complementary multidevice approach to treatment.
    Jilaihawi H; Bonan R; Asgar A; Ibrahim R; Spyt T; Chin D; Kovac J
    JACC Cardiovasc Interv; 2010 Aug; 3(8):859-66. PubMed ID: 20723859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves.
    Eggebrecht H; Schäfer U; Treede H; Boekstegers P; Babin-Ebell J; Ferrari M; Möllmann H; Baumgartner H; Carrel T; Kahlert P; Lange P; Walther T; Erbel R; Mehta RH; Thielmann M
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1218-27. PubMed ID: 22115663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transapical transcatheter aortic valve implantation: follow-up to 3 years.
    Ye J; Cheung A; Lichtenstein SV; Nietlispach F; Albugami S; Masson JB; Thompson CR; Munt B; Moss R; Carere RG; Jamieson WR; Webb JG
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1107-13, 1113.e1. PubMed ID: 20412948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valve-in-valve implantation of Medtronic CoreValve prosthesis in patients with failing bioprosthetic aortic valves.
    Linke A; Woitek F; Merx MW; Schiefer C; Möbius-Winkler S; Holzhey D; Rastan A; Ender J; Walther T; Kelm M; Mohr FW; Schuler G
    Circ Cardiovasc Interv; 2012 Oct; 5(5):689-97. PubMed ID: 23048050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcatheter valve-in-valve implantation with the Edwards SAPIEN in patients with bioprosthetic heart valve failure: the Milan experience.
    Latib A; Ielasi A; Montorfano M; Maisano F; Chieffo A; Cioni M; Mussardo M; Bertoldi L; Shannon J; Sacco F; Covello RD; Figini F; Godino C; Grimaldi A; Spagnolo P; Alfieri O; Colombo A
    EuroIntervention; 2012 Mar; 7(11):1275-84. PubMed ID: 22278193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and prognosis of vascular complications after transcatheter aortic valve implantation.
    Mwipatayi BP; Picardo A; Masilonyane-Jones TV; Larbalestier R; Thomas S; Turner J; Vijayan V; Yong G
    J Vasc Surg; 2013 Oct; 58(4):1028-36.e1. PubMed ID: 23993436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis.
    Wijesinghe N; Ye J; Rodés-Cabau J; Cheung A; Velianou JL; Natarajan MK; Dumont E; Nietlispach F; Gurvitch R; Wood DA; Tay E; Webb JG
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1122-5. PubMed ID: 21087746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immediate and mid-term results of transfemoral aortic valve implantation using either the Edwards Sapien transcatheter heart valve or the Medtronic CoreValve System in high-risk patients with aortic stenosis.
    Attias D; Himbert D; Ducrocq G; Détaint D; Al-Attar N; Iung B; Francis F; Maury JM; Brochet E; Enguerrand D; Nataf P; Vahanian A
    Arch Cardiovasc Dis; 2010 Apr; 103(4):236-45. PubMed ID: 20656634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN™ and Medtronic CoreValve ReValving System® devices: the Milan registry.
    Buchanan GL; Chieffo A; Montorfano M; Maisano F; Latib A; Godino C; Cioni M; Gullace MA; Franco A; Gerli C; Alfieri O; Colombo A
    EuroIntervention; 2011 Sep; 7(5):556-63. PubMed ID: 21930459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergency cardiac surgery during transfemoral and transapical transcatheter aortic valve implantation: incidence, reasons, management, and outcome of 411 patients from a single center.
    Griese DP; Reents W; Kerber S; Diegeler A; Babin-Ebell J
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):E726-33. PubMed ID: 23765631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry.
    Staubach S; Franke J; Gerckens U; Schuler G; Zahn R; Eggebrecht H; Hambrecht R; Sack S; Richardt G; Horack M; Senges J; Steinberg DH; Ledwoch J; Fichtlscherer S; Doss M; Wunderlich N; Sievert H;
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):348-55. PubMed ID: 22566406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transapical versus transfemoral aortic valve implantation: a multicenter collaborative study.
    van der Boon RM; Marcheix B; Tchetche D; Chieffo A; Van Mieghem NM; Dumonteil N; Vahdat O; Maisano F; Serruys PW; Kappetein AP; Fajadet J; Colombo A; Carrié D; van Domburg RT; de Jaegere PP
    Ann Thorac Surg; 2014 Jan; 97(1):22-8. PubMed ID: 24263012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of transcatheter aortic valve replacement in patients with chronic liver disease.
    Shah AM; Ogbara J; Herrmann HC; Fox Z; Kadakia M; Anwaruddin S; Bavaria JE; Desai ND; Jagasia D; Szeto WY; Li RH; Vallabhajosyula P; Giri J
    Catheter Cardiovasc Interv; 2015 Nov; 86(5):888-94. PubMed ID: 25963625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of Life Shift after Aortic Valve Replacement in the Era of TAVI: Single-Center Class Comparison Study Between Different Procedural Techniques.
    Blehm A; Sorokin VA; Hartman M; Wai KL; Schmitz K; Lichtenberg A
    J Heart Valve Dis; 2015 Sep; 24(5):540-53. PubMed ID: 26897832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.